FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

FDA Withdraws 6 No-Longer-Marketed ANDAs

Federal Register notice: FDA withdraws approval of six ANDAs from multiple applicants after they notified the agency that the products were no longer ...

Federal Register

Info Collection on Expanded Access

Federal Register notice: FDA seeks comments on an information collection revision entitled Expanded Access to Investigational Drugs for Treatment Use....

Human Drugs

Pfizer Covid Oral Drug 89% Effective

Pfizer says new data on its Covid-19 oral antiviral drug Paxlovid (nirmatrelvir tablets and ritonavir tablets) show the drug significantly reduced the...

Biologics

Significant HCT/P Deviations at Cooper Institute

FDA warns Houstons Cooper Institute for Advanced Reproductive Medicine about significant deviations from the regulations for human cells, tissues, and...

Human Drugs

Covid-19 Actemra REMS Guidance

FDA issues a guidance modifying REMS requirements for Genentechs Actemra under certain conditions during the Covid-19-related Actemra shortage.

Medical Devices

FDA Approves 2 Svelte Stent Systems

FDA approves two Svelte Medical drug-eluting stent systems.

Human Drugs

Multiple Violations Found in Sanitor Inspection

FDA warns Stanton, CA-based Sanitor about CGMP and other violations in its manufacturing of misbranded unapproved new drugs.

Medical Devices

QS Violations at DeVilbiss Healthcare

FDA warns Port Washington, NY-based DeVilbiss Healthcare about Quality System regulation violations in the firms manufacturing of oxygen concentrators...

Human Drugs

Court Tosses California Pay for Delay Ban

A California federal judge says a state law banning pay-for-delay generic drug agreements likely violates out-of-state commerce protections.

Federal Register

Info Collection on Expanded Access

Federal Register notice: FDA seeks comments on an information collection revision entitled Expanded Access to Investigational Drugs for Treatment Use....